Key Statistics for ACT
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ACT
- Net Income (M/USD)
Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.
More Company Profile & Key Executives for ACT
|Paul M BisaroChairman||R Todd JoyceChief Financial Ofcr:Global|
|James D'AreccaChief Accounting Officer||Charles M MayrChief Communications Ofcr:Global|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.